Keyphrases
Programmed Death-ligand 1 (PD-L1)
100%
Cytotoxic T Cells
100%
Therapeutic Targeting
100%
Small Molecule Inhibitors
100%
Solid Tumor Microenvironment
100%
Small Molecules
80%
Clinical Outcomes
40%
Infiltration
40%
Tumor Microenvironment
40%
Monoclonal Antibody
20%
Cytotoxic T Lymphocytes
20%
Immune Checkpoint Inhibitors
20%
T Cells
20%
Adaptive Immune Response
20%
T Cell Activation
20%
Human Cancer
20%
Immunotherapeutics
20%
Cancer Immunotherapy
20%
Biological Products
20%
In Silico Analysis
20%
Three-dimensional Solid
20%
Unveiling
20%
Anti-PD-1 Antibody
20%
Effector Memory T Cells
20%
Solid Tumor Model
20%
Transdisciplinary Approach
20%
PD-1 Signaling Pathway
20%
Medicine and Dentistry
Cytotoxic T-Cell
100%
Solid Malignant Neoplasm
100%
Tumor Microenvironment
100%
Malignant Neoplasm
33%
In Vitro
33%
In Silico
33%
Immune Checkpoint Inhibitor
33%
Monoclonal Antibody
33%
Signal Transduction
33%
T Cell
33%
Ex Vivo
33%
Cancer Immunotherapy
33%
Tumor Model
33%
Adaptive Immunity
33%
T Lymphocyte
33%
Cell Function
33%
Immunomodulating Agent
33%
Programmed Death 1 Receptor
33%
Immunology and Microbiology
T Cell
100%
Cytotoxic T Cell
100%
Monoclonal Antibody
50%
Monospecific Antibody
50%
Signal Transduction
50%
Cell Function
50%
Computer Model
50%
Adaptive Immune System
50%
Cytotoxic T-Cell
50%
Cancer Immunotherapy
50%
Immunomodulating Drugs
50%
Programmed Death 1 Receptor
50%
Pharmacology, Toxicology and Pharmaceutical Science
Solid Malignant Neoplasm
100%
Tumor Microenvironment
100%
Malignant Neoplasm
66%
Monoclonal Antibody
33%
Tumor Model
33%
Immunotherapy
33%
Immune Checkpoint Inhibitor
33%
Programmed Death 1 Receptor
33%
CD8 Antigen
33%
Immunomodulating Agent
33%
Biochemistry, Genetics and Molecular Biology
Small Molecule
100%
Cytotoxic T Cell
100%
T Cell
60%
Signal Transduction
20%
Monospecific Antibody
20%
Cell Death
20%
Computer Model
20%
Immune Checkpoints
20%
Cell Function
20%
Synapsin I
20%
Monoclonal Antibody
20%
Cancer Immunotherapy
20%
Adaptive Immunity
20%
CD8
20%